Loading…

Proteomics-based target identification: bengamides as a new class of methionine aminopeptidase inhibitors

LAF389 is a synthetic analogue of bengamides, a class of marine natural products that produce inhibitory effects on tumor growth in vitro and in vivo. A proteomics-based approach has been used to identify signaling pathways affected by bengamides. LAF389 treatment of cells resulted in altered mobili...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of biological chemistry 2003-12, Vol.278 (52), p.52964-52971
Main Authors: Towbin, Harry, Bair, Kenneth W, DeCaprio, James A, Eck, Michael J, Kim, Sunkyu, Kinder, Frederick R, Morollo, Anthony, Mueller, Dieter R, Schindler, Patrick, Song, Hyun Kyu, van Oostrum, Jan, Versace, Richard W, Voshol, Hans, Wood, Jeanette, Zabludoff, Sonya, Phillips, Penny E
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:LAF389 is a synthetic analogue of bengamides, a class of marine natural products that produce inhibitory effects on tumor growth in vitro and in vivo. A proteomics-based approach has been used to identify signaling pathways affected by bengamides. LAF389 treatment of cells resulted in altered mobility of a subset of proteins on two-dimensional gel electrophoresis. Detailed analysis of one of the proteins, 14-3-3gamma, showed that bengamide treatment resulted in retention of the amino-terminal methionine, suggesting that bengamides directly or indirectly inhibited methionine aminopeptidases (MetAps). Both known MetAps are inhibited by LAF389. Short interfering RNA suppression of MetAp2 also altered amino-terminal processing of 14-3-3gamma. A high resolution structure of human MetAp2 co-crystallized with a bengamide shows that the compound binds in a manner that mimics peptide substrates. Additionally, the structure reveals that three key hydroxyl groups on the inhibitor coordinate the di-cobalt center in the enzyme active site.
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.M309039200